We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi-Aventis Receives Pediatric Exclusivity for Ambien
Sanofi-Aventis Receives Pediatric Exclusivity for Ambien
November 30, 2006
The FDA granted pediatric exclusivity for insomnia drugs Ambien and Ambien CR, giving sanofi-aventis six more months of patent protection, the company announced.